VRM Cyclotron introduces Central India's first medical cyclotron facility, established on a 7-acre innovation campus. The center features a GE PETtraceTM 890 (16.5 MeV) Self-Shielded Medical Cyclotron, Comecer Hot Cells, GE FASTIabTM 2 radiochemistry modules, and a Therodico-2 automated dispensing suite, creating a world-class environment for radiopharmaceutical production, imaging, and research.
“VRM Molecular and Nuclear Medicine Pvt. Ltd. is proud to establish Central India’s first Cyclotron, enabling local radiopharmaceutical production to support advanced PET imaging. This initiative ensures timely access, consistent quality, and cost-effective nuclear medicine solutions—reinforcing our commitment to excellence, innovation, and service to humanity.”
| Tracer / Isotope | Target Mechanism | Clinical Indications |
|---|---|---|
| 18F-FDG | Glucose metabolism | Oncology, infection, neurology |
| 18F-FLT | DNA synthesis | Therapy response, tumor proliferation |
| 18F-PSMA | PSMA receptor | Prostate cancer |
| 18F-FCH | Membrane synthesis | Prostate, HCC, parathyroid adenoma |
| 18F-FET | Amino acid transport | Glioma & brain tumor imaging |
| 18F-FES | Estrogen receptor | ER-positive breast/gynecologic cancers |
| 18F-FDOPA | Dopaminergic pathway | NETS, Parkinson's, pediatric glioma |
| 18F-FAPI | Fibroblast activation | Pan-tumor, fibrotic & inflammatory diseases |
| 13N-Ammonia | Myocardial perfusion | Coronary artery disease & viability |
| 68Ga-DOTATATE / PSMA | Receptor binding | NETS & prostate cancer |
Ujjain's location at the geographic center of India enables fast and reliable distribution of short half-life PET tracers to major cities within 6—8 hours - including Indore, Bhopal, Nagpur, Jaipur, Raipur, Nashik and all over India.
The VRm Cyclotron campus is designed for scalability and long-term expansion, ith dedicated vaults, cleanroom labs, QC suites, and future research zones.
High-yield Fluorine-18 (18F) production at 7.5 Ci / 648 GBq per batch, with readiness for Nitrogen-13 (13N—Ammonia) and Gallium-68 (68Ga) tracer manufacturing.
Built to support academic collaboration, tracer innovation, and physician training programs in partnership with hospitals and universities.
Fully AERB-licensed and GMP-certified, operating under WHO-grade harmaceutical standards, ensuring consistent purity, sterility, and safety.
Cyclotron
Completely seize cross functional resources without resource maximizing process improvements. Globally monetize front-end channels after
Dispenser
Hot Cells
FASTIab
Founder Chairman
Dr. Vinod Bhandari is a visionary leader whose commitment to excellence has played a pivotal role in shaping VRM Cyclotron into a center of reliability, innovation, and advanced medical technology. With a deep understanding of healthcare systems and a strong belief in purposeful progress, he has consistently guided the organization toward meaningful contributions in the field of nuclear medicine and diagnostic imaging.
Under his leadership, VRM Cyclotron has embraced cutting-edge cyclotron technology to support accurate diagnostics, advanced radiopharmaceutical production, and high-quality clinical applications. Dr. Vinod Bhandari firmly believes that technology must ultimately serve humanity, and this philosophy reflects in the institution’s patient-focused approach, uncompromising safety standards, and dedication to quality.
Read More
Chief Executive Officer (CEO)
Mr. Danish Suleman is a results-driven Chief Executive Officer with a strong strategic vision and a proven record of leading organizations through growth, transformation, and long-term value creation. With deep experience in corporate strategy, business development, and operations, he has successfully driven market expansion, organizational change, and sustainable performance.
Known for clear direction and disciplined execution, he aligns teams around measurable outcomes while balancing innovation with operational excellence and financial control. He brings strong expertise in governance, stakeholder management, and board-level decision-making, navigating complex regulatory environments with confidence.
Committed to building high-performance leadership teams and accountable cultures, Mr. Danish Suleman leads with integrity, transparency, and a global perspective grounded in local market insight, focusing on responsible growth and enduring institutional success.
Read More
Director
Dr. Mohit Bhandari is a globally renowned bariatric, metabolic, and endoscopic surgeon, widely recognized for his pioneering role in advanced weight-loss and minimally invasive metabolic care.
With over 30,000 bariatric and metabolic procedures performed, he stands among the highest-volume bariatric surgeons in the world.
He is a pioneer of robotic bariatric surgery in India, including the country’s first robotic duodenal switch, significantly advancing complex metabolic procedures.
Dr. Bhandari is also a leader in endoscopic weight-loss innovations, with one of the earliest and highest volumes of Endoscopic Sleeve Gastroplasty in Asia.
He has introduced multiple first-of-their-kind technologies and procedures in India, expanding both surgical and non-surgical obesity treatment options.
Read More
Executive Director
Dr. Anil Kumar Mishra is the Chief Executive Director of VRM Molecular & Nuclear Medicine Pvt. Ltd. and a globally recognized leader in molecular imaging and radiopharmaceutical sciences with over 37 years of experience. He holds a Ph.D. in Chemistry from Banaras Hindu University and has conducted advanced research at prestigious institutions in France, Germany, and the USA.
Formerly the Director of INMAS, DRDO (Delhi), Dr. Mishra spearheaded India’s strategic initiatives in cyclotron and radiopharmaceutical sciences, leading the indigenous development of PET and SPECT radiotracers. He pioneered one of India’s earliest structured academia–industry collaborations with Dabur Research Foundation, establishing a sustainable translational research model.
A recipient of numerous national and international honors, including the DRDO Young Scientist Award (1999) presented by the Hon’ble Prime Minister of India, Dr. Mishra has led major projects funded by DRDO, DST, DBT, IAEA, and international programs. His scholarly contributions include 295+ publications, 7,000+ citations, and multiple global patents.
Read More
Managing Director
MOHD DAUD is an accomplished healthcare professional with over 25 years of experience in healthcare infrastructure, operations, and technology-enabled services. He has led complex, highly regulated healthcare environments with a strong emphasis on quality, safety, regulatory compliance, and operational efficiency.
He brings deep expertise in end-to-end project execution, regulatory coordination, and vendor and stakeholder management, working closely with hospitals, service providers, technology partners, and statutory authorities. His ability to align clinical, technical, and administrative teams has been key to the successful delivery of large-scale healthcare and nuclear medicine infrastructure projects.
As Managing Director of VRM, MOHD DAUD provides strategic direction focused on process excellence, risk mitigation, and continuous improvement, ensuring the development of robust, scalable, and compliant systems that support safe and efficient healthcare operations.
Read MoreCHECK GALLERY
